Bioventures 2014 (b), L.p. Mpm
Former 10% Owner at Werewolf Therapeutics, Inc. (HOWL); 10% Owner at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $799K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | TRDAEntrada Therapeutics, Inc. | Sell | 38,9224,279,426 held (−1%) | $7.20 | $280K | -21.3% |
| Aug 31SEC | TRDAEntrada Therapeutics, Inc. | Sell | 3,7334,275,693 held (−0%) | $7.01 | $26K | -19.1% |
| Aug 31SEC | TRDAEntrada Therapeutics, Inc. | Sell | 44,2594,231,434 held (−1%) | $6.99 | $309K | -18.9% |
| Dec 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 59,2774,924,566 held (−1%) | $0.89 | $53K | +10.1% |
| Dec 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 57,2254,867,341 held (−1%) | $0.87 | $50K | +12.6% |
| Dec 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 83,2304,784,111 held (−2%) | $0.97 | $81K | +1.0% |
- Sell
Former 10% Owner Bioventures 2014 (b), L.p. Mpm sold $53K of HOWL at $0.89 — pre-scheduled 10b5-1 plan sale.
- Sell
Former 10% Owner Bioventures 2014 (b), L.p. Mpm sold $50K of HOWL at $0.87 — pre-scheduled 10b5-1 plan sale.
- Sell
Former 10% Owner Bioventures 2014 (b), L.p. Mpm sold $81K of HOWL at $0.97 — pre-scheduled 10b5-1 plan sale.